Join
Live feed
·
PRReleasevia Quantisnow
Agios Pharmaceuticals Inc. logo

Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress

ByQuantisnow·Wall Street's wire, on your screen.
AGIO· Agios Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AGIO (Agios Pharmaceuticals Inc.) and more on Quantisnow.